First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study.
Saved in:
| Title: | First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study. |
|---|---|
| Authors: | Kournoutas I; Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States., Marell P; Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States., Gile J; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Peersen A; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN 55905, United States., Shah P; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., VanDommelen K; Department of Hematology/Oncology, Cleveland Clinic Cancer Center, Cleveland, OH 44195, United States., Kamath SD; Department of Hematology/Oncology, Cleveland Clinic Cancer Center, Cleveland, OH 44195, United States., Gupta G; Division of Hematology/Oncology, University of Alabama, Birmingham, AL 35294, United States., Akce M; Division of Hematology/Oncology, University of Alabama, Birmingham, AL 35294, United States., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States., Chen PJ; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States., Naleid N; Department of Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH 44106, United States., Mahipal A; Department of Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH 44106, United States., Peterson N; Division of Medical Oncology, University of Michigan, Ann Arbor, MI 48019, United States., Sahai V; Division of Medical Oncology, University of Michigan, Ann Arbor, MI 48019, United States., Wee Ma W; Department of Hematology/Oncology, Cleveland Clinic Cancer Center, Cleveland, OH 44195, United States., Jin Z; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Halfdanarson T; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Fonkoua Kankeu L; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Washburn LA; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Conboy CB; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Torbenson M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States., Goenka A; Department of Radiology, Mayo Clinic, Rochester, MN 55905, United States., Thompson S; Department of Radiology, Mayo Clinic, Rochester, MN 55905, United States., Venkatesh SK; Department of Radiology, Mayo Clinic, Rochester, MN 55905, United States., Starlinger P; Department of Surgery, Mayo Clinic, Rochester, MN 55905, United States., Roberts L; Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, United States., Gores GJ; Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, United States., Babiker H; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL 32224, United States., Ahn D; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ 85259, United States., Borad M; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ 85259, United States., Bekaii-Saab T; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ 85259, United States., Jatoi A; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., McWilliams RR; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Ou FS; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN 55905, United States., Tran NH; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States. |
| Source: | The oncologist [Oncologist] 2025 Nov 11; Vol. 30 (11). |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyaf286 |
